Our first priority is to bring visibility into existing solutions and projects in development that are grounded in data and have been validated by experts. We invite the world’s innovators to share solutions, learnings and resources and allow the global community to:

Participate in the latest breakthroughs, research and solutions in development

Ask the network for help in scaling the impact of promising and vetted COVID-19 solutions

GCP research credits can advance your research by giving you access to computing power that will make the next big thing possible. We’re funding projects from modeling the outbreak of COVID19 to predicting sepsis and discovering new planets. We look forward to supporting the next big breakthrough.

Funding for novel conceptual frameworks or theory-based approaches that present disruptive ways of thinking about fundamental scientific problems that have evaded resolution, propose new, paradigm-shifting scientific directions, and/or address fundamental and important questions that are argued to be undervalued by the scientific community. Approaches can include analytical reasoning, calculations, simulations, and thought experiments.

Science funding mechanisms are too slow in normal times and may be much too slow during the COVID-19 pandemic. Fast Grants are an effort to correct this. If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 48 hours. If we approve the grant, you'll receive payment as quickly as your university can receive it.

The purpose of this funding opportunity is to provide emergency funding for federally recognized tribes, tribal organizations, consortia of federally recognized tribes, or their bona fide agents that represent tribal components of the public health system to carry out COVID-19 preparedness and response activities.

The American Heart Association (AHA) invites cardiovascular-focused applications that will contribute to understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social behaviors which can lead to dissemination, containment, and complications of COVID-19. Because of the urgency of this issue, innovative, highly impactful short-term proposals (9-12 months), which can show progress within the period of this award, are sought.

The listed topics of interest are:
• Topic #1: Surveillance, natural history and household transmission of SARS CoV-2 DVD/RVB
• Topic #2: Diagnostics development and novel technology development and evaluation to improve diagnostic testing capabilities for COVID-19 detection DVD/RVB
• Topic #3: Immune response and transmission dynamics for SARS CoV-2 DVD/RVB
• Topic #4: Host infection dynamics for SARS CoV-2 DVD/RVB
• Topic #5: Prospective Cohorts to Assess COVID-19 and Other Respiratory Diseases

Grant funding may be used to provide direct assistance to economically vulnerable individuals and families impacted by COVID 19. Such assistance may include the provision of food, housing, utilities, transportation, childcare, education, and/or health services. Grant funding may not be utilized to develop or implement new programs or services not in place prior to March 11, 2020

COVID 19 Therapeutics Accelerator - $150 million: The funding will help strengthen detection, isolation and treatment efforts; protect at-risk populations; and develop vaccines, treatments and diagnostics. The R&D efforts are focused on developing new drugs, as well as exploring the possibilities to repurpose existing medicines. This work will leverage the power of partnership to develop, manufacture, and distribute effective treatments—and quickly. The COVID-19 Therapeutics Accelerator will not be conducting a traditional funding call.

Carlos Slim Foundation allocates 1bn pesos US ($41 million) for Covid-19 prevention and treatment in Mexico. The donation will go toward the purchase of medical equipment and public health educational resources